Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_382
Snippet: In conclusion, fecal dysbiosis is present in cats with CE. Although the FCEAI decreased significantly after 4 weeks of medical treatment, the abundance of selected bacterial groups did not change significantly. Results might suggest that a longer period of treatment or a different approach to medical therapy (i.e., pre-or probiotics) may be needed for cats to recover from fecal dysbiosis associated with CE. In human medicine, recent studies have .....
Document: In conclusion, fecal dysbiosis is present in cats with CE. Although the FCEAI decreased significantly after 4 weeks of medical treatment, the abundance of selected bacterial groups did not change significantly. Results might suggest that a longer period of treatment or a different approach to medical therapy (i.e., pre-or probiotics) may be needed for cats to recover from fecal dysbiosis associated with CE. In human medicine, recent studies have shown that individuals with inflammatory bowel disease (IBD) have statistically significant decreases in mean platelet volume (MPV) and platelet distribution width (PDW) and increases in platelet crit (PCT) compared to healthy controls. In remission, PDW and PCT have been found to be significantly greater than in controls. No studies to date have investigated the association between platelet indices in dogs with IBD compared to healthy controls and to determine if platelet indices could be useful predictors of disease presence or severity. Therefore, the purpose of this retrospective study was to determine if any platelet indices are significantly different between dogs diagnosed with IBD and healthy matched control dogs, or if any indices are predictive of severity based on canine chronic enteropathy clinical activity index (CCECAI) scores assigned retrospectively to dogs diagnosed with IBD.
Search related documents:
Co phrase search for related documents- bacterial group and disease presence: 1
- bacterial group and healthy control: 1, 2
- bacterial group and human medicine: 1, 2
- bowel disease and clinical activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- bowel disease and clinical activity index: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- bowel disease and date study: 1
- bowel disease and disease presence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- bowel disease and fecal dysbiosis: 1
- bowel disease and healthy control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- bowel disease and human medicine: 1, 2, 3, 4
- bowel disease and IBD diagnose: 1
- CCECAI score and clinical activity: 1, 2
- CCECAI score and clinical activity index: 1
- CCECAI score and disease presence: 1
- CCECAI score and healthy control: 1
- clinical activity and date study: 1
- clinical activity and disease presence: 1, 2, 3, 4, 5
- clinical activity and healthy control: 1, 2, 3, 4, 5, 6, 7
- clinical activity index and healthy control: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date